Decisiones sanitarias - Open Access .click

Results 131 to 140 of about 1,389 (206)

Neuropsychiatric Adverse Events Associated With Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Clinical Practice: A Multicenter Study

European Journal of Neurology, Volume 33, Issue 7, July 2026.
In 214 patients with advanced Parkinson's disease receiving foslevodopa/foscarbidopa continuous subcutaneous infusion, neuropsychiatric adverse events occurred in 19.2%. Baseline cognitive impairment and hallucinations did not increase risk, whereas preexisting impulse control disorders predicted ICD‐related adverse events.
David Campo‐Caballero +130 more
wiley +1 more source

Differences in Fat Depots, Cardiometabolic Risk Factors, and Insulin Resistance Between Active and Passive School Commuters

Pediatric Obesity, Volume 21, Issue 7, July 2026.
ABSTRACT Background Active commuting to and from school (ACS) is a feasible strategy to increase daily physical activity in children. Although ACS has been associated with favourable body composition and selected cardiometabolic markers, its association with specific ectopic fat depots remains unclear in paediatric populations.
David Rodriguez‐Sanchez +6 more
wiley +1 more source

[Interdependent islands: health policies and medical practices in the care, management, and research of a neglected disease in the Global South]. [PDF]

Cad Saude Publica
Silveti L, Pereira AMM.
europepmc +1 more source

Influence and convergence to higher standards: The dual examination of pharmaceutical patents in Brazil

The Journal of World Intellectual Property, Volume 29, Issue 2, Page 381-401, July 2026.
Abstract Between 2001 and 2021, pharmaceutical patent applications filed in Brazil were examined by the patent office (INPI) and the national health regulator (Anvisa). This paper investigates how health regulators can contribute to patent examination by shifting the set of criteria cited as grounds for 2589 negative decisions from both entities ...
Eduardo Mercadante
wiley +1 more source

[Prescribing medicines in primary care teams: the challenge of multidisciplinarity and patient safety]. [PDF]

Aten Primaria
Luzón-Oliver L, Astier-Peña MP.
europepmc +1 more source

Evaluación de tecnologías sanitarias para la toma de decisiones y la rendición de cuentas: una urgente reflexión para el sistema de salud chileno [PDF]

Value in Health Regional Issues, 2017
Espinoza Sepúlveda, Manuel Antonio, Vargas, C. +1 more
openaire +3 more sources

Inteligencia artificial en atención primaria: efectos y controversias sociales. Revisión sistemática de la bibliografía. [PDF]

Aten Primaria
Prat-Carreño M, Umaña V, Bermejo V, Vallès-Peris N. +3 more
europepmc +1 more source

Valoración de la madurez para la toma de decisiones sanitarias en menores afectos de enfermedad aguda y crónica en un contexto hospitalario

, 2020
INTRODUCCIÓ: La participació de el menor en la presa de decisions és un aspecte clau en el nou marc ètic i legal de desenvolupament de la medicina actual. Aquesta participació s'ha de fer de manera progressiva i d'acord amb la maduresa de el menor.
openaire +2 more sources

[SEFAC's 25th anniversary: consolidating evidence, planning for the future]. [PDF]

Farm Comunitarios
Spanish Society of Community Pharmacy Research (SEFAC).
europepmc +1 more source

[The "good author"]. [PDF]

Rev Med Inst Mex Seguro Soc
Chávez-Martínez O.
europepmc +1 more source

medicine
ra1-1270
public aspects of medicine

salud pública
toma de decisiones
covid-19

3. good health
medicine general
r5-920